These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12640271)

  • 1. Immunotherapy in the prophylaxis and treatment of neonatal sepsis.
    Suri M; Harrison L; Van de Ven C; Cairo MS
    Curr Opin Pediatr; 2003 Apr; 15(2):155-60. PubMed ID: 12640271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulins and haematopoietic growth factors in the prevention and treatment of neonatal sepsis: ground reality or glorified myths?
    Shaw CK; Thapalial A; Shaw P; Malla K
    Int J Clin Pract; 2007 Mar; 61(3):482-7. PubMed ID: 17313617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
    Parravicini E; van de Ven C; Anderson L; Cairo MS
    Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of myeloid colony-stimulating factors in neonates with septicemia.
    Bernstein HM; Calhoun DA; Christensen RD
    Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?
    La Gamma EF; De Castro MH
    Acta Paediatr Suppl; 2002; 91(438):109-16. PubMed ID: 12477273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using granulocyte colony-stimulating factor for neutropenia during neonatal sepsis.
    Murray JC; McClain KL; Wearden ME
    Arch Pediatr Adolesc Med; 1994 Jul; 148(7):764-6. PubMed ID: 7517276
    [No Abstract]   [Full Text] [Related]  

  • 8. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.
    Banerjea MC; Speer CP
    Semin Neonatol; 2002 Aug; 7(4):335-49. PubMed ID: 12401303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial sepsis in neonatal intensive care: inevitable or preventable?
    Bersani I; Speer CP
    Z Geburtshilfe Neonatol; 2012 Aug; 216(4):186-90. PubMed ID: 22926819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to the prevention and therapy of neonatal bacterial sepsis.
    Perez EM; Weisman LE
    Clin Perinatol; 1997 Mar; 24(1):213-29. PubMed ID: 9099511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis in babies: should we stimulate the phagocytes?
    Shann F
    Lancet; 2009 Jan; 373(9659):188-90. PubMed ID: 19150690
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
    Goldman S; Ellis R; Dhar V; Cairo MS
    Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins in neonatal sepsis: has the final word been said?
    Capasso L; Borrelli AC; Ferrara T; Coppola C; Cerullo J; Izzo F; Caiazza R; Lama S; Raimondi F
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S47-9. PubMed ID: 25220128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
    Mohan P; Brocklehurst P
    Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood component and immunotherapy in neonatal sepsis.
    Sweetman RW; Cairo MS
    Transfus Med Rev; 1995 Jul; 9(3):251-9. PubMed ID: 7549235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal sepsis: pathogenesis and supportive therapy.
    Wolach B
    Semin Perinatol; 1997 Feb; 21(1):28-38. PubMed ID: 9190031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New modalities for treating neonatal infection.
    Bedford-Russell AR
    Eur J Pediatr; 1996 Aug; 155 Suppl 2():S21-4. PubMed ID: 8839742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.